Guardant Health
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Trade Guardant Health 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About GH
Guardant Health, Inc. is a precision oncology company, which engages in the provision of treatment of cancer through the use of proprietary blood-based tests, vast data sets, and advanced analytics. Its solutions include treatment selection, recurrence detection, and early detection.
CEOHelmy Eltoukhy
CEOHelmy Eltoukhy
Employees2,021
Employees2,021
HeadquartersPalo Alto, California
HeadquartersPalo Alto, California
Founded2011
Founded2011
Employees2,021
Employees2,021
GH Key Statistics
Market cap11.51B
Market cap11.51B
Price-Earnings ratio-21.60
Price-Earnings ratio-21.60
Dividend yield—
Dividend yield—
Average volume2.48M
Average volume2.48M
High today$95.88
High today$95.88
Low today$88.00
Low today$88.00
Open price$89.98
Open price$89.98
Volume6.41M
Volume6.41M
52 Week high$95.88
52 Week high$95.88
52 Week low$21.28
52 Week low$21.28
GH News
TipRanks 21h
Guardant Health reports Q3 EPS (39c), consensus (49c)Reports Q3 revenue $265.2M, consensus $235.7M. “This was an exceptional quarter for Guardant with broad-based growth across our business,” said Helmy Eltoukhy,...
Investor's Business Daily 21h
Why IBD 50's Guardant Health, Up 137% in 2025, Could Surge AgainGuardant Health (GH) on Wednesday posted results that smashed Wall Street's third-quarter expectations. The Palo Alto, Calif.-based company is best-known for i...
Simply Wall St 4d
Could Guardant Health's Expansive ESMO 2025 Data Redefine Its Long-Term Innovation Edge?Guardant Health announced that it recently presented new data from 15 oncology studies spanning multiple cancer types at the European Society for Medical Oncolo...
Analyst ratings
88%
of 26 ratingsBuy
88.5%
Hold
7.7%
Sell
3.8%
People also own
Based on the portfolios of people who own GH. This list is generated using Robinhood data, and it’s not a recommendation.